These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17429847)

  • 21. T cell-related costimulatory molecules in the conjunctiva of patients with severe allergic conjunctivitis.
    Sumi T; Ishida W; Ebihara N; Fukushima A
    Cornea; 2010 Jun; 29(6):622-7. PubMed ID: 20458217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth.
    Kim EY; Teh SJ; Yang J; Chow MT; Teh HS
    J Immunol; 2009 Nov; 183(10):6051-7. PubMed ID: 19841176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine.
    Cayeux S; Bukarica B; Buschow C; Charo J; Bunse M; Dörken B; Blankenstein T
    Gene Ther; 2007 Oct; 14(20):1481-91. PubMed ID: 17700709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity.
    Kilinc MO; Gu T; Harden JL; Virtuoso LP; Egilmez NK
    J Immunol; 2009 Apr; 182(7):4217-25. PubMed ID: 19299720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioning.
    Chang L; Chang WC; McNamara G; Aguilar B; Ostberg JR; Jensen MC
    Cytotherapy; 2007; 9(8):771-84. PubMed ID: 17917884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
    Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ
    Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct demonstration of CD4 T cell cooperation in the primary in vivo generation of CD4 effector T cells.
    Kroeger DR; Rudulier CD; Peters NC; Bretscher PA
    Int Immunol; 2012 Aug; 24(8):519-27. PubMed ID: 22527289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OX40 ligation enhances cell cycle turnover of Ag-activated CD4 T cells in vivo.
    Weatherill AR; Maxwell JR; Takahashi C; Weinberg AD; Vella AT
    Cell Immunol; 2001 Apr; 209(1):63-75. PubMed ID: 11414737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
    Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
    Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-OX40 (CD134) administration to nonhuman primates: immunostimulatory effects and toxicokinetic study.
    Weinberg AD; Thalhofer C; Morris N; Walker JM; Seiss D; Wong S; Axthelm MK; Picker LJ; Urba WJ
    J Immunother; 2006; 29(6):575-85. PubMed ID: 17063120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+ T cells in adoptive immunotherapy and the indirect mechanism of tumor rejection.
    Cohen PA; Peng L; Plautz GE; Kim JA; Weng DE; Shu S
    Crit Rev Immunol; 2000; 20(1):17-56. PubMed ID: 10770269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costimulation of CD8 T cell responses by OX40.
    Bansal-Pakala P; Halteman BS; Cheng MH; Croft M
    J Immunol; 2004 Apr; 172(8):4821-5. PubMed ID: 15067059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-treatment with cyclophosphamide or OX40 (CD134) costimulation targeting regulatory T cell function enhances the anti-tumor immune effect of adoptively transferred CD8+ T cells from wild-type mice.
    Ueki T; Murata S; Kitamura N; Mekata E; Tani T
    Mol Med Rep; 2009; 2(4):615-20. PubMed ID: 21475875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased OX40 and soluble OX40 ligands in children with Henoch-Schonlein purpura: association with renal involvement.
    Qin W; Hongya W; Yongjing C; Fang X; Yue M; Xuekun Z; Xiaozhong L; Xueguang Z
    Pediatr Allergy Immunol; 2011 Feb; 22(1 Pt 1):54-9. PubMed ID: 21143648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OX40 signaling is involved in the autoactivation of CD4
    Jiang J; Liu C; Liu M; Shen Y; Hu X; Wang Q; Wu J; Wu M; Fang Q; Zhang X
    Arthritis Res Ther; 2017 Mar; 19(1):67. PubMed ID: 28320444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depletion of CD8+ or CD4+ lymphocytes enhances susceptibility to transplantable ultraviolet radiation-induced skin tumours.
    Vanbuskirk A; Oberyszyn TM; Kusewitt DF
    Anticancer Res; 2005; 25(3B):1963-7. PubMed ID: 16158931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.
    Bansal-Pakala P; Jember AG; Croft M
    Nat Med; 2001 Aug; 7(8):907-12. PubMed ID: 11479622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist.
    Redmond WL; Gough MJ; Charbonneau B; Ratliff TL; Weinberg AD
    J Immunol; 2007 Dec; 179(11):7244-53. PubMed ID: 18025166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.